Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes

Trevor J. Pitcher, Gregory D. Gromowski, David Beasley, Alan Barrett

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The envelope (E) protein is composed of three domains (ED1, ED2 and ED3) with ED3 targeted by the most potent neutralizing antibodies. DENV-2 strains can be divided into six genotypes. Comparison of ED3 of representative strains of the six genotypes revealed that there are nine variable residues that are specific to a given genotype. Recombinant ED3s (rED3s) of six different DENV-2 strains representing all nine variable residues were expressed, and their reactivity against a panel of two DENV-2 type-specific and three DENV complex-reactive monoclonal antibodies (mAbs) were compared. The differences in binding affinity to the rED3s representing different DENV-2 genotypes were relatively small, with the exception of type-specific-mAb 3H5 that showed up to 10-fold differences in binding between genotypes. Overall the binding differences did not lead to detectable differences in neutralization. Based on these results, DENV-2 ED3-specific neutralizing antibodies will likely be effective against DENV-2 strains from all six genotypes.

Original languageEnglish (US)
Pages (from-to)386-392
Number of pages7
JournalVirology
Volume422
Issue number2
DOIs
StatePublished - Jan 20 2012

Fingerprint

Catalytic Domain
Genotype
Neutralizing Antibodies
Monoclonal Antibodies
Proteins

Keywords

  • Antibody-mediated neutralization
  • Antigenic sites
  • DENV-2 genotypes

ASJC Scopus subject areas

  • Virology

Cite this

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes. / Pitcher, Trevor J.; Gromowski, Gregory D.; Beasley, David; Barrett, Alan.

In: Virology, Vol. 422, No. 2, 20.01.2012, p. 386-392.

Research output: Contribution to journalArticle

@article{d08a0d01cef0451ea5d79982bc6e9e78,
title = "Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes",
abstract = "The envelope (E) protein is composed of three domains (ED1, ED2 and ED3) with ED3 targeted by the most potent neutralizing antibodies. DENV-2 strains can be divided into six genotypes. Comparison of ED3 of representative strains of the six genotypes revealed that there are nine variable residues that are specific to a given genotype. Recombinant ED3s (rED3s) of six different DENV-2 strains representing all nine variable residues were expressed, and their reactivity against a panel of two DENV-2 type-specific and three DENV complex-reactive monoclonal antibodies (mAbs) were compared. The differences in binding affinity to the rED3s representing different DENV-2 genotypes were relatively small, with the exception of type-specific-mAb 3H5 that showed up to 10-fold differences in binding between genotypes. Overall the binding differences did not lead to detectable differences in neutralization. Based on these results, DENV-2 ED3-specific neutralizing antibodies will likely be effective against DENV-2 strains from all six genotypes.",
keywords = "Antibody-mediated neutralization, Antigenic sites, DENV-2 genotypes",
author = "Pitcher, {Trevor J.} and Gromowski, {Gregory D.} and David Beasley and Alan Barrett",
year = "2012",
month = "1",
day = "20",
doi = "10.1016/j.virol.2011.10.020",
language = "English (US)",
volume = "422",
pages = "386--392",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes

AU - Pitcher, Trevor J.

AU - Gromowski, Gregory D.

AU - Beasley, David

AU - Barrett, Alan

PY - 2012/1/20

Y1 - 2012/1/20

N2 - The envelope (E) protein is composed of three domains (ED1, ED2 and ED3) with ED3 targeted by the most potent neutralizing antibodies. DENV-2 strains can be divided into six genotypes. Comparison of ED3 of representative strains of the six genotypes revealed that there are nine variable residues that are specific to a given genotype. Recombinant ED3s (rED3s) of six different DENV-2 strains representing all nine variable residues were expressed, and their reactivity against a panel of two DENV-2 type-specific and three DENV complex-reactive monoclonal antibodies (mAbs) were compared. The differences in binding affinity to the rED3s representing different DENV-2 genotypes were relatively small, with the exception of type-specific-mAb 3H5 that showed up to 10-fold differences in binding between genotypes. Overall the binding differences did not lead to detectable differences in neutralization. Based on these results, DENV-2 ED3-specific neutralizing antibodies will likely be effective against DENV-2 strains from all six genotypes.

AB - The envelope (E) protein is composed of three domains (ED1, ED2 and ED3) with ED3 targeted by the most potent neutralizing antibodies. DENV-2 strains can be divided into six genotypes. Comparison of ED3 of representative strains of the six genotypes revealed that there are nine variable residues that are specific to a given genotype. Recombinant ED3s (rED3s) of six different DENV-2 strains representing all nine variable residues were expressed, and their reactivity against a panel of two DENV-2 type-specific and three DENV complex-reactive monoclonal antibodies (mAbs) were compared. The differences in binding affinity to the rED3s representing different DENV-2 genotypes were relatively small, with the exception of type-specific-mAb 3H5 that showed up to 10-fold differences in binding between genotypes. Overall the binding differences did not lead to detectable differences in neutralization. Based on these results, DENV-2 ED3-specific neutralizing antibodies will likely be effective against DENV-2 strains from all six genotypes.

KW - Antibody-mediated neutralization

KW - Antigenic sites

KW - DENV-2 genotypes

UR - http://www.scopus.com/inward/record.url?scp=84855195471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855195471&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2011.10.020

DO - 10.1016/j.virol.2011.10.020

M3 - Article

VL - 422

SP - 386

EP - 392

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -